Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-16

Clinical Trial Update: LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's Disease

View source ↗

Summary

This clinical trial update reports on LRRK2, GBA and other genetic biomarkers studied in Eastern European Ashkenazi Jewish individuals with and without Parkinso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Parkinson Disease, LRRK2 | Status: COMPLETED